High dose versus low dose medroxyprogesterone acetate: a randomized trial in advanced breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference25 articles.
1. A possible new approach to the treatment of metastatic breast cancer;Pannuti,1978
2. High dose medroxyprogesterone acetate (MPA) treatment in metastatic carcinoma of the breast: a dose response evaluation;Robustelli Della Cuna;Tumori,1978
3. High dose medroxyprogesterone acetate in treatment in advanced mammary carcinoma;Mattson,1978
4. High dose medroxyprogesterone acetate in breast resistant to endocrine and cytotoxic therapy;De Lena;Cancer Chemother Pharmacol,1979
5. Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of post-menopausal patients with advanced breast cancer;Cavalli;J Clin Oncol,1984
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007;Breast Cancer Research and Treatment;2014-09-26
2. Hormontherapie beim metastasierten Mammakarzinom der Frau;DMW - Deutsche Medizinische Wochenschrift;2008-03-25
3. Mammakarzinom der Frau;Kompendium Internistische Onkologie;2006
4. Medroxyprogesterone Acetate Elevation of Nm23-H1 Metastasis Suppressor Expression in Hormone Receptor–Negative Breast Cancer;JNCI: Journal of the National Cancer Institute;2005-05-04
5. Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer;Cancer Treatment Reviews;2000-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3